Lots of Biotech News

This is shaping up to be a busy week for biotech investors. Tomorrow, Genentech (Ticker: DNA) will be reporting Q1 earnings after the bell. Everyone is looking for in line numbers of $0.67 per share and $2.74 billion in revenues, but beating the numbers will be nice. This Saturday is the start of the American Association for Cancer Research (AACR) conference out in LA. So look for news coming out of the conference. And finally, Vertex Pharmaceuticals (Ticker: VRTX) will be announcing on Saturday night phase II results on their hepatitis C treatment at European Association for the Study of the Liver. So everyone, place your bets...